Who invested in Immunicom

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$3.9Mraised across 2 rounds since 2019, from 2 sources

$1.9MSeries B$2.0MGrant

Latest round: Grant, $2.0MJun 2022
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202020212022

$1.9MSeries B$2.0MGrant

First round: Series B, $1.9M
Biggest round: $2.0M
Between rounds: 2.7 years

The rounds

Jun 2022
Grant$2.0M2 new
- National Institutes of Health
- National Cancer Institute (NCI)
Source recorded
Oct 2019
Series B$1.9M
No investor was named in the report.
Reported by FinSMEs

Founders and team

From Immunicom's own website: 1 founder, 4 on the team.

Amir JafriCEO, Founder

Marilyn PanahiVice President of Quality
Lawrence FlorinChief Clinical Officer
Raju ChauhanChief Operating Officer
Reza IlkhaniChief Financial Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2019Grant2022

National Institutes of HealthNational Cancer Institute (NCI)

Everyone who backed them

National Institutes of HealthGovernment1round

National Cancer Institute (NCI)Investment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Immunicom as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.